Langton, David J. http://orcid.org/0000-0003-1178-3031
Bhalekar, Rohan M.
Joyce, Thomas J.
Rushton, Stephen P.
Wainwright, Benjamin J.
Nargol, Matthew E. http://orcid.org/0000-0002-7261-6192
Shyam, Nish http://orcid.org/0000-0002-8420-9770
Lie, Benedicte A.
Pabbruwe, Moreica B. http://orcid.org/0000-0002-4223-0416
Stewart, Alan J. http://orcid.org/0000-0003-4580-1840
Waller, Susan
Natu, Shonali
Ren, Renee
Hornick, Rachelle
Darlay, Rebecca
Su, Edwin P.
Nargol, Antoni V. F.
Funding for this research was provided by:
Innovate UK Edge, commercial funding.
Article History
Received: 24 September 2021
Accepted: 7 June 2022
First Online: 24 June 2022
Change Date: 15 July 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s43856-022-00158-9
Competing interests
: The authors declare the following competing interests: the algorithm described in this study has been developed into software to be used as a commercial medical device (Orthotype). Orthotype has been patented, and is owned by the company PXD Ltd, trading as ExplantLab. David Langton, the lead author, is director of this company. Matthew Nargol is an employee of ExplantLab. All other authors have no competing interests to declare.